The partnership is poised to increase patient impact, especially for those who would benefit from enhanced care co-ordination ...

Investors burned by President Trump’s trade fight now have to contend with a spending megabill that risks swelling the ...

Fed officials say debt downgrade complicates inflation outlook, Nvidia CEO discusses China chip ban, JPMorgan’s investor day, ...

The US’s credit rating took a hit on Friday, after Moody’s downgraded the country’s AAA rating. And then yesterday, bond ...

The Moody’s announcement sent the yield on a 30-year Treasury bond to a high of 5.01% at one point on Monday. Bond yields ...

Regeneron to rescue 23andMe in a $256 million deal, raising major questions about DNA privacy, genetic data ownership, and ...

The FTSE 100 , US markets and European stocks were mixed on Monday, as a new deal was struck between the EU and UK and ...

Dow Jones Top Company Headlines at 11 AM ET: Regeneron to Buy 23andMe Out of Bankruptcy for $256 Million | JPMorgan ... The move raises privacy concerns as the drugmaker takes control of the genetic ...

The fall of 23andMe raises privacy concerns as Regeneron buys its genetic database for $256M after bankruptcy.

Morning! Today we start with some breaking newss: Novo Nordisk’s CEO is stepping down. We also discuss a new, tailored CRISPR treatment for an infant with a deadly disease, how Amgen owes Regeneron ...

DZ Bank has significantly reduced its holdings in Regeneron Pharmaceuticals, offloading 74.4% of its shares in Q4. Despite ...

Regeneron earns a buy rating with strong profit margins, low debt, and growth potential. Discover why shares may see a 39% ...